News

Scientists in Japan have uncovered a surprising twist, literally, in how molecules organize themselves. By introducing tiny leftover fragments from previous assemblies, they discovered a way to flip ...
Cytochrome P450 (CYP) proteins are responsible for breaking down more than 80% of all Food and Drug Administration ...
A team of researchers from China and the US has introduced a new method to improve the performance of high-enthalpy elastic materials utilizing a technique called twist buckling. The new design could ...
Understand the significant growth trajectory of the Intermediates segment, which is expected to reach US$8.2 Billion by 2030 with a CAGR of a 3.4%. The Analytical segment is also set to grow at 4.8% ...
They are also called nonsteroidal anti-inflammatory drugs (NSAIDs). NSAIDs block an enzyme called cyclooxygenase (or COX) used by the body to make prostaglandins. Prostaglandins are chemicals in your ...
Artificial intelligence (AI) has taken the biotech industry by storm, allowing companies to speed up the drug discovery process while also making it more cost-effective. With so many companies in the ...
A new study has discovered what researchers say is the first drug to fully reproduce the effects of physical stroke rehabilitation in model mice, following from human studies. A new study by UCLA ...
Further research revealed that one of these drugs, DDL-920 – developed at UCLA, led to the complete recovery of movement control – something many stroke patients never regain.
From Neural Data to Cognitive AI: Training Chiral™ – As the leader in scalable neurotechnology through its transcatheter approach, Synchron, in collaboration with NVIDIA, will train Chiral ...
Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, 310015 Hangzhou, Zhejiang, China ...
Synchron Showcases the Future of AI-Driven Brain-Computer Interfaces at NVIDIA GTC 2025 NEW YORK--(BUSINESS WIRE)--#BCI--Synchron, a category-defining brain-computer interface (BCI) company, today ...